• [1]
    Savage, D.C. (1977) Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol 31, 107133.
  • [2]
    Mackie, R.I., Sghir, A., Gaskins, H.R. (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr 69, 1035S1045S.
  • [3]
    Mccracken, V.J., Lorenz, R.G. (2001) The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell. Microbiol 3, 111.
  • [4]
    Berg, R.D. (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4, 430435.
  • [5]
    Morelli, L., Cesena, C., De Haen, C., Gozzini, L. (1998) Taxonomic Lactobacillus composition of feces from human newborns during the first few days. Microb. Ecol 35, 205212.
  • [6]
    Vaughan, E.E., Schut, F., Heilig, H.G., Zoetendal, E.G., De Vos, W.M., Akkermans, A.D. (2000) A molecular view of the intestinal ecosystem. Curr. Issues Intest. Microbiol 1, 112.
  • [7]
    Zboril, V. (2002) Physiology of microflora in the digestive tract. Vnitr. Lek 48, 1721.
  • [8]
    Roach, S., Savage, D.C., Tannock, G.W. (1977) Lactobacilli isolated from the stomach of conventional mice. Appl. Environ. Microbiol 33, 11971203.
  • [9]
    Uribe, A., Alam, M., Johansson, O., Midtvedt, T., Theodorsson, E. (1994) Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology 107, 12591269.
  • [10]
    Bry, L., Falk, P.G., Midtvedt, T., Gordon, J.I. (1996) A model of host–microbial interactions in an open mammalian ecosystem. Science 273, 13801383.
  • [11]
    Falk, P.G., Hooper, L.V., Midtvedt, T., Gordon, J.I. (1998) Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev 62, 11571170.
  • [12]
    Hooper, L.V., Xu, J., Falk, P.G., Midtvedt, T., Gordon, J.I. (1999) A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. USA 96, 98339838.
  • [13]
    Putsep, K., Axelsson, L.G., Boman, A., Midtvedt, T., Normark, S., Boman, H.G., Andersson, M. (2000) Germ-free and colonized mice generate the same products from enteric prodefensins. J. Biol. Chem 275, 4047840482.
  • [14]
    Lopez-Boado, Y.S., Wilson, C.L., Hooper, L.V., Gordon, J.I., Hultgren, S.J., Parks, W.C. (2000) Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J. Cell. Biol 148, 13051315.
  • [15]
    Hooper, L.V., Gordon, J.I. (2001) Commensal host–bacterial relationships in the gut. Science 292, 11151118.
  • [16]
    Hooper, L.V., Wong, M.H., Thelin, A., Hansson, L., Falk, P.G., Gordon, J.I. (2001) Molecular analysis of commensal host–microbial relationships in the intestine. Science 291, 881884.
  • [17]
    Freitas, M., Axelsson, L.G., Cayuela, C., Midtvedt, T., Trugnan, G. (2002) Microbial–host interactions specifically control the glycosylation pattern in intestinal mouse mucosa. Histochem. Cell. Biol 118, 149161.
  • [18]
    Freitas, M., Cayuela, C., Antoine, J.M., Piller, F., Sapin, C., Trugnan, G. (2001) A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells. Cell. Microbiol 3, 289300.
  • [19]
    Wilson, C.L., Ouellette, A.J., Satchell, D.P., Ayabe, T., Lopez-Boado, Y.S., Stratman, J.L., Hultgren, S.J., Matrisian, L.M., Parks, W.C. (1999) Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113117.
  • [20]
    Cebra, J.J. (1999) Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr 69, 1046S1051S.
  • [21]
    Talham, G.L., Jiang, H.Q., Bos, N.A., Cebra, J.J. (1999) Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect. Immun 67, 19922000.
  • [22]
    Kagnoff, M.F., Eckmann, L. (1997) Epithelial cells as sensors for microbial infection. J. Clin. Invest 100, 610.
  • [23]
    Bevins, C.L., Martin-Porter, E., Ganz, T. (1999) Defensins and innate host defence of the gastrointestinal tract. Gut 45, 911915.
  • [24]
    Ouellette, A.J. Am. J. Physiol. 277, 1999. G257–261
  • [25]
    Corfield, A.P., Myerscough, N., Longman, R., Sylvester, P., Arul, S., Pignatelli, M. (2000) Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 47, 589594.
  • [26]
    Louvard, D., Kedinger, M., Hauri, H.P. (1992) The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures. Annu. Rev. Cell. Biol 8, 157195.
  • [27]
    Kedinger, M., Duluc, I., Fritsch, C., Lorentz, O., Plateroti, M., Freund, J.N. (1998) Intestinal epithelial–mesenchymal cell interactions. Ann. N.Y. Acad. Sci 859, 117.
  • [28]
    Montgomery, R.K., Mulberg, A.E., Grand, R.J. (1999) Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology 116, 702731.
  • [29]
    Anderson, J.M., Balda, M.S., Fanning, A.S. (1993) The structure and regulation of tight junctions. Curr. Opin. Cell. Biol 5, 772778.
  • [30]
    Balda, M.S., Matter, K. (1998) Tight junctions. J. Cell. Sci 111, 541547.
  • [31]
    Cereijido, M., Valdes, J., Shoshani, L., Contreras, R.G. (1998) Role of tight junctions in establishing and maintaining cell polarity. Annu. Rev. Physiol 60, 161177.
  • [32]
    Citi, S., Cordenonsi, M. (1998) Tight junction proteins. Biochim. Biophys. Acta 1448, 111.
  • [33]
    Madara, J.L. (1998) Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol 60, 143159.
  • [34]
    Cossart, P., Boquet, P., Normark, S., Rappuoli, R. (1996) Cellular microbiology emerging. Science 271, 315316.
  • [35]
    Cossart, P. (1997) Host/pathogen interactions. Subversion of the mammalian cell cytoskeleton by invasive bacteria. J. Clin. Invest 99, 23072311.
  • [36]
    Finlay, B.B., Cossart, P. (1997) Exploitation of mammalian host cell functions by bacterial pathogens. Science 276, 718725.
  • [37]
    Finlay, B.B., Falkow, S. (1997) Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev 61, 136169.
  • [38]
    Laboisse, C., Jarry, A., Branka, J.E., Merlin, D., Bou-Hanna, C., Vallette, G. (1995) Regulation of mucin exocytosis from intestinal goblet cells. Biochem. Soc. Trans 23, 810813.
  • [39]
    Forstner, G. (1995) Signal transduction, packaging and secretion of mucins. Annu. Rev. Physiol 57, 585605.
  • [40]
    Kraehenbuhl, J.P., Neutra, M.R. (2000) Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol 16, 301332.
  • [41]
    M.R. Neutra N.J. Mantis J.P. Kraehenbuhl Collaboration of epithelial cells with organized mucosal lymphoid tissues, Nat. Immunol. 2, 2001. 10041009.
  • [42]
    Didierlaurent, A., Sirard, J.C., Kraehenbuhl, J.P., Neutra, M.R. (2002) How the gut senses its content. Cell. Microbiol 4, 6172.
  • [43]
    Aderem, A., Ulevitch, R.J. (2000) Toll-like receptors in the induction of the innate immune response. Nature 406, 782787.
  • [44]
    Bals, R. (2000) Epithelial antimicrobial peptides in host defense against infection. Respir. Res 1, 141150.
  • [45]
    Bals, R. (2000) Antimicrobial peptides and peptide antibiotics. Med. Klin 95, 496502.
  • [46]
    Boman, H.G. (2000) Innate immunity and the normal microflora. Immunol. Rev 173, 516.
  • [47]
    Cunliffe, R.N., Mahida, Y.R. (2000) Antimicrobial peptides in innate intestinal host defence. Gut 47, 1617.
  • [48]
    Ganz, T., Lehrer, R.I. (1998) Antimicrobial peptides of vertebrates. Curr. Opin. Immunol 10, 4144.
  • [49]
    Ganz, T. (2001) Antimicrobial proteins and peptides in host defense. Semin. Respir. Infect 16, 410.
  • [50]
    Hiemstra, P.S. (2001) Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation. Paediatr. Respir. Rev 2, 306310.
  • [51]
    Huttner, K.M., Bevins, C.L. (1999) Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res 45, 785794.
  • [52]
    Lehrer, R.I., Ganz, T. (1999) Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol 11, 2327.
  • [53]
    Mahida, Y.R., Rose, F., Chan, W.C. (1997) Antimicrobial peptides in the gastrointestinal tract. Gut 40, 161163.
  • [54]
    Rao, A.G. (1995) Antimicrobial peptides. Mol. Plant. Microbe Interact 8, 613.
  • [55]
    Bevins, C.L. (1994) Antimicrobial peptides as agents of mucosal immunity. Ciba Found. Symp 186, 250260.
  • [56]
    Ayabe, T., Satchell, D.P., Wilson, C.L., Parks, W.C., Selsted, M.E., Ouellette, A.J. (2000) Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol 1, 113118.
  • [57]
    O`neil, D.A., Porter, E.M., Elewaut, D., Anderson, G.M., Eckmann, L., Ganz, T., Kagnoff, M.F. (1999) Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol 163, 67186724.
  • [58]
    Takahashi, A., Wada, A., Ogushi, K., Maeda, K., Kawahara, T., Mawatari, K., Kurazono, H., Moss, J., Hirayama, T., Nakaya, Y. (2001) Production of beta-defensin-2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein. FEBS Lett 508, 484488.
  • [59]
    Ogushi, K., Wada, A., Niidome, T., Mori, N., Oishi, K., Nagatake, T., Takahashi, A., Asakura, H., Makino, S., Hojo, H., Nakahara, Y., Ohsaki, M., Hatakeyama, T., Aoyagi, H., Kurazono, H., Moss, J., Hirayama, T. (2001) Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells. J. Biol. Chem 276, 3052130526.
  • [60]
    Salzman, N.H., Chou, M.M., De Jong, H., Liu, L., Porter, E.M., Paterson, Y. (2003) Enteric Salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect. Immun 71, 11091115.
  • [61]
    Islam, D., Bandholtz, L., Nilsson, J., Wigzell, H., Christensson, B., Agerberth, B., Gudmundsson, G. (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med 7, 180185.
  • [62]
    Gunn, J.S., Miller, S.I. (1996) PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J. Bacteriol 178, 68576864.
  • [63]
    Groisman, E.A., Parra-Lopez, C., Salcedo, M., Lipps, C.J., Heffron, F. (1992) Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc. Natl. Acad. Sci. USA 89, 1193911943.
  • [64]
    Miller, S.I., Pulkkinen, W.S., Selsted, M.E., Mekalanos, J.J. (1990) Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect. Immun 58, 37063710.
  • [65]
    Nicaise, P., Gleizes, A., Sandre, C., Kergot, R., Lebrec, H., Forestier, F., Labarre, C. (1999) The intestinal microflora regulates cytokine production positively in spleen-derived macrophages but negatively in bone marrow-derived macrophages. Eur. Cytokine Netw 10, 365372.
  • [66]
    Hudault, S., Guignot, J., Servin, A.L. (2001) Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut 49, 4755.
  • [67]
    Riley, M.A., Wertz, J.E. (2002) Bacteriocin diversity: ecological and evolutionary perspectives. Biochimie 84, 357364.
  • [68]
    Ramare, F., Nicoli, J., Dabard, J., Corring, T., Ladire, M., Gueugneau, A.M., Raibaud, P. (1993) Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro. Appl. Environ. Microbiol 59, 28762883.
  • [69]
    Dabard, J., Bridonneau, C., Phillipe, C., Anglade, P., Molle, D., Nardi, M., Ladire, M., Girardin, H., Marcille, F., Gomez, A., Fons, M. (2001) Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl. Environ. Microbiol 67, 41114118.
  • [70]
    Gomez, A., Ladire, M., Marcille, F., Fons, M. (2002) Trypsin mediates growth phase-dependent transcriptional regulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota. J. Bacteriol 184, 1828.
  • [71]
    Mccartney, A.L., Wenzhi, W., Tannock, G.W. (1996) Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl. Environ. Microbiol 62, 46084613.
  • [72]
    Reuter, G. (2001) The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr. Issues Intest. Microbiol 2, 4353.
  • [73]
    Tannock, G.W. (2002) The bifidobacterial and Lactobacillus microflora of humans. Clin. Rev. Allergy Immunol 22, 231253.
  • [74]
    Hopkins, M.J., Sharp, R., Macfarlane, G.T. (2002) Variation in human intestinal microbiota with age. Dig. Liver Dis 34 (Suppl. 2), S12S18.
  • [75]
    Salminen, S., Deighton, M. (1992) Lactic acid bacteria in the gut in normal and disordered states. Dig. Dis 10, 227238.
  • [76]
    Salminen, S., Bouley, C., Boutron-Ruault, M.C., Cummings, J.H., Franck, A., Gibson, G.R., Isolauri, E., Moreau, M.C., Roberfroid, M., Rowland, I. (1998) Functional food science and gastrointestinal physiology and function. Br. J. Nutr 80 (Suppl. 1), S147S171.
  • [77]
    Kailasapathy, K., Chin, J. (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol 78, 8088.
  • [78]
    Rolfe, R.D. (2000) The role of probiotic cultures in the control of gastrointestinal health. J. Nutr 130, 396S402S.
  • [79]
    Saavedra, J. (2000) Probiotics and infectious diarrhea. Am. J. Gastroenterol 95, S16S18.
  • [80]
    Morelli, L. (2000) In vitro selection of probiotic lactobacilli: a critical appraisal. Curr. Issues Intest. Microbiol 1, 5967.
  • [81]
    Alvarez-Olmos, M.I., Oberhelman, R.A. (2001) Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin. Infect. Dis 32, 15671576.
  • [82]
    Elmer, G.W. (2001) Probiotics: “living drugs”. Am. J. Health-Syst. Ph 58, 11011109.
  • [83]
    Elmer, G.W., Mcfarland, L.V. (2001) Biotherapeutic agents in the treatment of infectious diarrhea. Gastroenterol. Clin. North Am 30, 837854.
  • [84]
    Szajewska, H., Mrukowicz, J.Z. (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr 33 (Suppl. 2), S17S25.
  • [85]
    Isolauri, E., Kirjavainen, P.V., Salminen, S. Probiotics: a role in the treatment of intestinal infection and inflammation?. Gut. 50, Suppl. 3, 2002. III54, III59
  • [86]
    Ouwehand, A.C., Salminen, S., Isolauri, E. (2002) Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82, 279289.
  • [87]
    Sullivan, A., Nord, C.E. (2002) The place of probiotics in human intestinal infections. Int. J. Antimicrob. Agents 20, 313319.
  • [88]
    Sullivan, A., Nord, C.E. (2002) Probiotics in human infections. J. Antimicrob. Chemother 50, 625627.
  • [89]
    Canducci, F., Cremonini, F., Armuzzi, A., Di Caro, S., Gabrielli, M., Santarelli, L., Nista, E., Lupascu, A., De Martini, D., Gasbarrini, A. (2002) Probiotics and Helicobacter pylori eradication. Dig. Liver Dis 34 (Suppl. 2), S8183.
  • [90]
    Cremonini, F., Di Caro, S., Covino, M., Armuzzi, A., Gabrielli, M., Santarelli, L., Nista, E.C., Cammarota, G., Gasbarrini, G., Gasbarrini, A. (2002) Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am. J. Gastroenterol 97, 27442749.
    Direct Link:
  • [91]
    Bruce, A.W., Reid, G. (1988) Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can. J. Microbiol 34, 339343.
  • [92]
    Reid, G., Sobel, J.D. (1987) Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev. Infect. Dis 9, 470487.
  • [93]
    Reid, G., Bruce, A.W., Mcgroarty, J.A., Cheng, K.J., Costerton, J.W. (1990) Is there a role for lactobacilli in prevention of urogenital and intestinal infections. Clin. Microbiol. Rev 3, 335344.
  • [94]
    Reid, G. (1999) The scientific basis for probiotic strains of Lactobacillus. Appl. Environ. Microbiol 65, 37633766.
  • [95]
    Boris, S., Barbes, C. (2000) Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect 2, 543546.
  • [96]
    Reid, G., Bruce, A.W. Could probiotics be an option for treating and preventing urogenital infections?. Medscape Womens Health. 6, 2001. 9
  • [97]
    Reid, G., Bruce, A.W., Fraser, N., Heinemann, C., Owen, J., Henning, B. (2001) Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol 30, 4952.
  • [98]
    Reid, G. (2002) The potential role of probiotics in pediatric urology. J. Urol 168, 15121517.
  • [99]
    Cadieux, P., Burton, J., Gardiner, G., Braunstein, I., Bruce, A.W., Kang, C.Y., Reid, G. (2002) Lactobacillus strains and vaginal ecology. JAMA 287, 19401941.
  • [100]
    Chan, R.C., Reid, G., Irvin, R.T., Bruce, A.W., Costerton, J.W. (1985) Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect. Immun 47, 8489.
  • [101]
    Reid, G., Chan, R.C., Bruce, A.W., Costerton, J.W. (1985) Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infect. Immun 49, 320324.
  • [102]
    Reid, G., Cook, R.L., Bruce, A.W. (1987) Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J. Urol 138, 330335.
  • [103]
    Zweibaum, A., Laburthe, M., Grasset, E., Louvard, D. Use of cultured cell lines in studies of intestinal cell differentiation and function. Handbook of Physiology, Schultz, S.J.F.M., Frizell, R.A., Eds., The Gastrointestinal System, Intestinal Absorption and Secretion. vol. IV, 1991. American Physiological Society, Bethesda. 223–255
  • [104]
    Chauviere, G., Coconnier, M.H., Kerneis, S., Fourniat, J., Servin, A.L. (1992) Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. J. Gen. Microbiol 138, 16891696.
  • [105]
    Coconnier, M.H., Klaenhammer, T.R., Kerneis, S., Bernet, M.F., Servin, A.L. (1992) Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture. Appl. Environ. Microbiol 58, 20342039.
  • [106]
    Bernet, M.F., Brassart, D., Neeser, J.R., Servin, A.L. (1994) Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35, 483489.
  • [107]
    Hudault, S., Lievin, V., Bernet-Camard, M.F., Servin, A.L. (1997) Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol 63, 513518.
  • [108]
    Tuomola, E.M., Salminen, S.J. (1998) Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int. J. Food Microbiol 41, 4551.
  • [109]
    Forestier, C., De Champs, C., Vatoux, C., Joly, B. (2001) Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol 152, 167173.
  • [110]
    Gopal, P.K., Prasad, J., Smart, J., Gill, H.S. (2001) In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food Microbiol 67, 207216.
  • [111]
    De Champs, C., Maroncle, N., Balestrino, D., Rich, C., Forestier, C. (2003) Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J. Clin. Microbiol 41, 12701273.
  • [112]
    Coconnier, M.H., Bernet, M.F., Chauviere, G., Servin, A.L. (1993) Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. J. Diarrhoeal Dis. Res 11, 235242.
  • [113]
    Sanders, M.E., Klaenhammer, T.R. (2001) Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J. Dairy Sci 84, 319331.
  • [114]
    Bibiloni, R., Perez, P.F., Garrote, G.L., Disalvo, E.A., De Antoni, G.L. (2001) Surface characterization and adhesive properties of bifidobacteria. Methods Enzymol 336, 411427.
  • [115]
    Bernet, M.F., Brassart, D., Neeser, J.R., Servin, A.L. (1993) Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen–cell interactions. Appl. Environ. Microbiol 59, 41214128.
  • [116]
    He, F., Ouwehan, A.C., Hashimoto, H., Isolauri, E., Benno, Y., Salminen, S. (2001) Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol. Immunol 45, 259262.
  • [117]
    He, F., Ouwehand, A.C., Isolauri, E., Hashimoto, H., Benno, Y., Salminen, S. (2001) Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol. Med. Microbiol 30, 4347.
  • [118]
    del Re, B., Sgorbati, B., Miglioli, M., Palenzona, D. (2000) Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol 31, 438442.
  • [119]
    Ouwehand, A.C., Isolauri, E., Kirjavainen, P.V., Salminen, S.J. (1999) Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol. Lett 172, 6164.
  • [120]
    Ouwehand, A.C., Isolauri, E., Kirjavainen, P.V., Tolkko, S., Salminen, S.J. (2000) The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett. Appl. Microbiol 30, 1013.
  • [121]
    Ouwehand, A.C., Salminen, S., Tolkko, S., Roberts, P., Ovaska, J., Salminen, E. (2002) Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin. Diagn. Lab. Immunol 9, 184186.
  • [122]
    Juntunen, M., Kirjavainen, P.V., Ouwehand, A.C., Salminen, S.J., Isolauri, E. (2001) Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin. Diagn. Lab. Immunol 8, 293296.
  • [123]
    Greene, J.D., Klaenhammer, T.R. (1994) Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl. Environ. Microbiol 60, 44874494.
  • [124]
    Blomberg, L., Henriksson, A., Conway, P.L. (1993) Inhibition of adhesion of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp. Appl. Environ. Microbiol 59, 3439.
  • [125]
    Ouwehand, A.C., Conway, P.L. (1996) Purification and characterization of a component produced by Lactobacillus fermentum that inhibits the adhesion of K88 expressing Escherichia coli to porcine ileal mucus. J. Appl. Bacteriol 80, 311318.
  • [126]
    Rojas, M., Conway, P.L. (1996) Colonization by lactobacilli of piglet small intestinal mucus. J. Appl. Bacteriol 81, 474480.
  • [127]
    Rojas, M., Ascencio, F., Conway, P.L. (2002) Purification and characterization of a surface protein from Lactobacillus fermentum 104R that binds to porcine small intestinal mucus and gastric mucin. Appl. Environ. Microbiol 68, 23302336.
  • [128]
    Granato, D., Perotti, F., Masserey, I., Rouvet, M., Golliard, M., Servin, A., Brassart, D. (1999) Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. Appl. Environ. Microbiol 65, 10711077.
  • [129]
    Gusils, C., Cuozzo, S., Sesma, F., Gonzalez, S. (2002) Examination of adhesive determinants in three species of Lactobacillus isolated from chicken. Can. J. Microbiol 48, 3442.
  • [130]
    Fernandez, M.F., Boris, S., Barbes, C. (2003) Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J. Appl. Microbiol 94, 449455.
  • [131]
    Ventura, M., Jankovic, I., Walker, D.C., Pridmore, R.D., Zink, R. (2002) Identification and characterization of novel surface proteins in Lactobacillus johnsonii and Lactobacillus gasseri. Appl. Environ. Microbiol 68, 61726181.
  • [132]
    Schell, M.A., Karmirantzou, M., Snel, B., Vilanova, D., Berger, B., Pessi, G., Zwahlen, M.C., Desiere, F., Bork, P., Delley, M., Pridmore, R.D., Arigoni, F. (2002) The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl. Acad. Sci. USA 99, 1442214427.
  • [133]
    Bernet-Camard, M.F., Lievin, V., Brassart, D., Neeser, J.R., Servin, A.L., Hudault, S. (1997) The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol 63, 27472753.
  • [134]
    Coconnier, M.H., Bernet, M.F., Kerneis, S., Chauviere, G., Fourniat, J., Servin, A.L. (1993) Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett 110, 299305.
  • [135]
    Hirano, J., Yoshida, T., Sugiyama, T., Koide, N., Mori, I., Yokochi, T. (2003) The effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitro. Microbiol. Immunol 47, 405409.
  • [136]
    Lee, Y.K., Puong, K.Y. (2002) Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Br. J. Nutr 88 (Suppl. 1), S101S108.
  • [137]
    Jin, L.Z., Ho, Y.W., Ali, M.A., Abdullah, N., Jalaludin, S. (1996) Effect of adherent Lactobacillus spp. on in vitro adherence of Salmonellae to the intestinal epithelial cells of chicken. J. Appl. Bacteriol 81, 201206.
  • [138]
    Spencer, R.J., Chesson, A. (1994) The effect of Lactobacillus spp. on the attachment of enterotoxigenic Escherichia coli to isolated porcine enterocytes. J. Appl. Bacteriol 77, 215220.
  • [139]
    Santos, A., San Mauro, M., Sanchez, A., Torres, J.M., Marquina, D. (2003) The antimicrobial properties of different strains of Lactobacillus spp. isolated from kefir. Syst. Appl. Microbiol 26, 434437.
  • [140]
    Lee, Y.J., Yu, W.K., Heo, T.R. (2003) Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. Int. J. Antimicrob. Agents 21, 340346.
  • [141]
    Tuomola, E.M., Ouwehand, A.C., Salminen, S.J. (1999) The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol. Med. Microbiol 26, 137142.
  • [142]
    Matsumoto, M., Tani, H., Ono, H., Ohishi, H., Benno, Y. (2002) Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr. Microbiol 44, 212215.
  • [143]
    Mack, D.R., Michail, S., Wei, S., Mcdougall, L., Hollingsworth, M.A. (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol 276, G941950.
  • [144]
    Lee, Y.K., Puong, K.Y., Ouwehand, A.C., Salminen, S. (2003) Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J. Med. Microbiol 52, 925930.
  • [145]
    Mattar, A.F., Teitelbaum, D.H., Drongowski, R.A., Yongyi, F., Harmon, C.M., Coran, A.G. (2002) Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr. Surg. Int 18, 586590.
  • [146]
    Lievin, V., Peiffer, I., Hudault, S., Rochat, F., Brassart, D., Neeser, J.R., Servin, A.L. (2000) Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47, 646652.
  • [147]
    Yamamoto, K., Miwa, T., Taniguchi, H., Nagano, T., Shimamura, K., Tanaka, T., Kumagai, H. (1996) Binding specificity of Lactobacillus to glycolipids. Biochem. Biophys. Res. Commun 228, 148152.
  • [148]
    Neeser, J.R., Granato, D., Rouvet, M., Servin, A., Teneberg, S., Karlsson, K.A. (2000) Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology 10, 11931199.
  • [149]
    Oro, H.S., Kolsto, A.B., Wenneras, C., Svennerholm, A.M. (1990) Identification of asialo GM1 as a binding structure for Escherichia coli colonization factor antigens. FEMS Microbiol. Lett 60, 289292.
  • [150]
    Fujiwara, S., Hashiba, H., Hirota, T., Forstner, J.F. (1997) Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl. Environ. Microbiol 63, 506512.
  • [151]
    Horie, M., Ishiyama, A., Fujihira-Ueki, Y., Sillanpaa, J., Korhonen, T.K., Toba, T. (2002) Inhibition of the adherence of Escherichia coli strains to basement membrane by Lactobacillus crispatus expressing an S-layer. J. Appl. Microbiol 92, 396403.
  • [152]
    Reid, G., Burton, J. (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4, 319324.
  • [153]
    Hautefort, I., Fléchon, B., Degrouard, J., Fons, M. (2000) Adhesion to the digestive mucosa is not sufficient for durable persistence of different Lactobacillus fermentum strains in the digestive tract of mice. Microb. Ecol. Health Dis 12, 4856.
  • [154]
    Kabir, A.M., Aiba, Y., Takagi, A., Kamiya, S., Miwa, T., Koga, Y. (1997) Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41, 4955.
  • [155]
    Matsumoto, S., Watanabe, N., Imaoka, A., Okabe, Y. (2001) Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence- accelerated mouse P1/Yit strain mice. Digestion 64, 9299.
  • [156]
    Bomba, A., Nemcova, R., Kastel, R., Herich, R., Pataky, J., Cizek, M. (1996) Interactions of Lactobacillus spp. and enteropathogenic Escherichia coli under in vitro and in vivo conditions. Vet. Med 41, 155158.
  • [157]
    Oozeer, R., Goupil-Feuillerat, N., Alpert, C.A., Van de Guchte, M., Anba, J., Mengaud, J., Corthier, G. (2002) Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl. Environ. Microbiol 68, 35703574.
  • [158]
    Crociani, J., Grill, J.P., Huppert, M., Ballongue, J. (1995) Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study. Lett. Appl. Microbiol 21, 146148.
  • [159]
    Locascio, M., Holgado, A.P., Perdigon, G., Oliver, G. (2001) Enteric bifidobacteria: isolation from human infants and challenge studies in mice. Can. J. Microbiol 47, 10481052.
  • [160]
    Frey, A., Neutra, M.R. Targeting of mucosal vaccines to Peyer's patch M cells. Behring Inst. Mitt. 1997. 376–389
  • [161]
    Wells, J.M., Robinson, K., Chamberlain, L.M., Schofield, K.M., le Page, R.W. (1996) Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek 70, 317330.
  • [162]
    Pouwels, P.H., Leer, R.J., Shaw, M., Heijne Den Bak-Glashouwer, M.J., Tielen, F.D., Smit, E., Martinez, B., Jore, J., Conway, P.L. (1998) Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int. J. Food Microbiol 41, 155167.
  • [163]
    Mercenier, A., Muller-Alouf, H., Grangette, C. (2000) Lactic acid bacteria as live vaccines. Curr. Issues Mol. Biol 2, 1725.
  • [164]
    Vesa, T., Pochart, P., Marteau, P. (2000) Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment. Pharmacol. Ther 14, 823828.
  • [165]
    Seegers, J.F. (2002) Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol 20, 508515.
  • [166]
    Scheppler, L., Vogel, M., Zuercher, A.W., Zuercher, M., Germond, J.E., Miescher, S.M., Stadler, B.M. (2002) Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 20, 29132920.
  • [167]
    Plant, L., Conway, P. (2001) Association of Lactobacillus spp. with Peyer's patches in mice. Clin. Diagn. Lab. Immunol 8, 320324.
  • [168]
    Aiba, Y., Suzuki, N., Kabir, A.M., Takagi, A., Koga, Y. (1998) Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol 93, 20972101.
    Direct Link:
  • [169]
    Coconnier, M.H., Lievin, V., Hemery, E., Servin, A.L. (1998) Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol 64, 45734580.
  • [170]
    Filho-Lima, J., Vieira, E., Nicoli, J. (2000) Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii, and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice. J. Appl. Microbiol 88, 365370.
  • [171]
    Gill, H.S., Shu, Q., Lin, H., Rutherfurd, K.J., Cross, M.L. (2001) Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med. Microbiol. Immunol 190, 97104.
  • [172]
    Coconnier, M.H., Lievin, V., Bernet-Camard, M.F., Hudault, S., Servin, A.L. (1997) Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob. Agents Chemother 41, 10461052.
  • [173]
    Pascual, M., Hugas, M., Badiola, J.I., Monfort, J.M., Garriga, M. (1999) Lactobacillus salivarius CTC2197 prevents Salmonella enteritidis colonization in chickens. Appl. Environ. Microbiol 65, 49814986.
  • [174]
    Shu, Q., Lin, H., Rutherfurd, K.J., Fenwick, S.G., Prasad, J., Gopal, P.K., Gill, H.S. (2000) Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiol. Immunol 44, 213222.
  • [175]
    Shu, Q., Gill, H.S. (2001) A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med. Microbiol. Immunol 189, 147152.
  • [176]
    Asahara, T., Nomoto, K., Shimizu, K., Watanuki, M., Tanaka, R. (2001) Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. J. Appl. Microbiol 91, 985996.
  • [177]
    Suzuki, T., Itoh, K., Kaneko, T., Suzuki, H. (1997) Inhibition of bacterial translocation from the gastrointestinal tract of mice by oral administration of a culture condensate of Bifidobacterium longum. J. Vet. Med. Sci 59, 665669.
  • [178]
    Shu, Q., Qu, F., Gill, H.S. (2001) Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J. Pediatr. Gastroenterol. Nutr 33, 171177.
  • [179]
    Mangell, P., Nejdfors, P., Wang, M., Ahrne, S., Westrom, B., Thorlacius, H., Jeppsson, B. (2002) Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig. Dis. Sci 47, 511516.
  • [180]
    Ogawa, M., Shimizu, K., Nomoto, K., Takahashi, M., Watanuki, M., Tanaka, R., Tanaka, T., Hamabata, T., Yamasaki, S., Takeda, Y. (2001) Protective effect of Lactobacillus casei strain Shirota on Shiga toxin- producing Escherichia coli O157:H7 infection in infant rabbits. Infect. Immun 69, 11011108.
  • [181]
    Bomba, A., Nemcova, R., Gancarcikova, S., Herich, R., Kastel, R. (1999) Potentiation of the effectiveness of Lactobacillus casei in the prevention of E. coli induced diarrhea in conventional and gnotobiotic pigs. Adv. Exp. Med. Biol 473, 185190.
  • [182]
    Sato, K. (1984) Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages. Infect. Immun 44, 445451.
  • [183]
    De Waard, R., Garssen, J., Bokken, G.C., Vos, J.G. (2002) Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats. Int. J. Food Microbiol 73, 93100.
  • [184]
    Yasui, H., Kiyoshima, J., Ushijima, H. (1995) Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064. J. Infect. Dis 172, 403409.
  • [185]
    Thoreux, K., Balas, D., Bouley, C., Senegas-Balas, F. (1998) Diet supplemented with yoghurt or milk fermented by Lactobacillus casei DN-114 001 stimulates growth and brush-border enzyme activities in mouse small intestine. Digestion 59, 349359.
  • [186]
    Guerin-Danan, C., Meslin, J.C., Chambard, A., Charpilienne, A., Relano, P., Bouley, C., Cohen, J., Andrieux, C. (2001) Food supplementation with milk fermented by Lactobacillus casei DN-114 001 protects suckling rats from rotavirus-associated diarrhea. J. Nutr 131, 111117.
  • [187]
    Qiao, H., Duffy, L.C., Griffiths, E., Dryja, D., Leavens, A., Rossman, J., Rich, G., Riepenhoff-Talty, M., Locniskar, M. (2002) Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatr. Res 51, 750755.
  • [188]
    FAO/WHO (2001) Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Available from:
  • [189]
    Borriello, S.P., Hammes, W.P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M., Valtonen, V. (2003) Safety of probiotics that contain lactobacilli or bifidobacteria. Clin. Infect. Dis 36, 775780.
  • [190]
    Apostolou, E., Kirjavainen, P.V., Saxelin, M., Rautelin, H., Valtonen, V., Salminen, S.J., Ouwehand, A.C. (2001) Good adhesion properties of probiotics: a potential risk for bacteremia. FEMS Immunol. Med. Microbiol 31, 3539.
  • [191]
    Asahara, T., Takahashi, M., Nomoto, K., Takayama, H., Onoue, M., Morotomi, M., Tanaka, R., Yokokura, T., Yamashita, N. (2003) Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin. Diagn. Lab. Immunol 10, 169173.
  • [192]
    Bezkorovainy, A. (2001) Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr 73, 399S405S.
  • [193]
    Charteris, W.P., Kelly, P.M., Morelli, L., Collins, J.K. (1998) Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol 84, 759768.
  • [194]
    Donnet-Hughes, A., Rochat, F., Serrant, P., Aeschlimann, J.M., Schiffrin, E.J. (1999) Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J. Dairy Sci 82, 863869.
  • [195]
    Goldin, B.R., Gorbach, S.L., Saxelin, M., Barakat, S., Gualtieri, L., Salminen, S. (1992) Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci 37, 121128.
  • [196]
    Tannock, G.W., Munro, K., Harmsen, H.J., Welling, G.W., Smart, J., Gopal, P.K. (2000) Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol 66, 25782588.
  • [197]
    Isolauri, E., Kaila, M., Mykkanen, H., Ling, W.H., Salminen, S. (1994) Oral bacteriotherapy for viral gastroenteritis. Dig. Dis. Sci 39, 25952600.
  • [198]
    Sarem-Damerdji, L., Sarem, F., Marchal, L., Nicolas, J.P. (1995) In vitro colonization ability of human colon mucosa by exogenous Lactobacillus strains. FEMS Microbiol. Lett 131, 133137.
  • [199]
    Saxelin, M., Pessi, T., Salminen, S. (1995) Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int. J. Food Microbiol 25, 199203.
  • [200]
    Alander, M., Korpela, R., Saxelin, M., Vilpponen-Salmela, T., Mattila-Sandholm, T., von Wright, A. (1997) Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett. Appl. Microbiol 24, 361364.
  • [201]
    Alander, M., Satokari, R., Korpela, R., Saxelin, M., Vilpponen-Salmela, T., Mattila-Sandholm, T., von Wright, A. (1999) Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol 65, 351354.
  • [202]
    Agarwal, R., Sharma, N., Chaudhry, R., Deorari, A., Paul, V.K., Gewolb, I.H., Panigrahi, P. (2003) Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J. Pediatr. Gastroenterol. Nutr 36, 397402.
  • [203]
    Cesena, C., Morelli, L., Alander, M., Siljander, T., Tuomola, E., Salminen, S., Mattila-Sandholm, T., Vilpponen-Salmela, T., von Wright, A. (2001) Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. J. Dairy Sci 84, 10011010.
  • [204]
    Guandalini, S. (2002) The treatment of acute diarrhea in the third millennium: a pediatrician's perspective. Acta Gastro-enterol. Belg 65, 3336.
  • [205]
    Rosenfeldt, V., Michaelsen, K.F., Jakobsen, M., Larsen, C.N., Moller, P.L., Tvede, M., Weyrehter, H., Valerius, N.H., Paerregaard, A. (2002) Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr. Infect. Dis. J 21, 417419.
  • [206]
    Rosenfeldt, V., Michaelsen, K.F., Jakobsen, M., Larsen, C.N., Moller, P.L., Pedersen, P., Tvede, M., Weyrehter, H., Valerius, N.H., Paerregaard, A. (2002) Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr. Infect. Dis. J 21, 411416.
  • [207]
    Shornikova, A.V., Casas, I.A., Mykkanen, H., Salo, E., Vesikari, T. (1997) Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J 16, 11031107.
  • [208]
    Shornikova, A.V., Casas, I.A., Isolauri, E., Mykkanen, H., Vesikari, T. (1997) Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr 24, 399404.
  • [209]
    Raza, S., Graham, S.M., Allen, S.J., Sultana, S., Cuevas, L., Hart, C.A., Kaila, M., Isolauri, E., Saxelin, M., Arvilommi, H. (1995) Lactobacillus GG in acute diarrhea. Indian Pediatr 32, 11401142.
  • [210]
    Guarino, A., Canani, R.B., Spagnuolo, M.I., Albano, F., Di Benedetto, L. (1997) Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr 25, 516519.
  • [211]
    Shornikova, A.V., Isolauri, E., Burkanova, L., Lukovnikova, S., Vesikari, T. (1997) A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 86, 460465.
  • [212]
    Majamaa, H., Isolauri, E., Saxelin, M., Vesikari, T. (1995) Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr 20, 333338.
  • [213]
    Oberhelman, R.A., Gilman, R.H., Sheen, P., Taylor, D.N., Black, R.E., Cabrera, L., Lescano, A.G., Meza, R., Madico, G. (1999) A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J. Pediatr 134, 1520.
  • [214]
    Sherwood, L., Gorbach, S.L. (2000) Probiotics and gastrointestinal health. Am. J. Gastroenterol 95, S24.
  • [215]
    Simakachorn, N., Pichaipat, V., Rithipornpaisarn, P., Kongkaew, C., Tongpradit, P., Varavithya, W. (2000) Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J. Pediatr. Gastroenterol. Nutr 30, 6872.
  • [216]
    Guandalini, S., Pensabene, L., Zikri, M.A., Dias, J.A., Casali, L.G., Hoekstra, H., Kolacek, S., Massar, K., Micetic-Turk, D., Papadopoulou, A., De Sousa, J.S., Sandhu, B., Szajewska, H., Weizman, Z. (2000) Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr 30, 5460.
  • [217]
    Van Niel, C.W., Feudtner, C., Garrison, M.M., Christakis, D.A. (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109, 678684.
  • [218]
    Hilton, E., Kolakowski, P., Singer, C., Smith, M. (1997) Efficacy of Lactobacillus GG as a diarrheal reventive in travelers. J. Travel Med 4, 4143.
  • [219]
    Dupont, H.L. (1997) Lactobacillus GG in prevention of traveler's diarrhea: an encouraging first step. J. Travel Med 4, 12.
  • [220]
    Dupont, H.L. (1999) Prevention of diarrhea by the probiotic, Lactobacillus GG. J. Pediatr 134, 12.
  • [221]
    Oksanen, P.J., Salminen, S., Saxelin, M., Hamalainen, P., Ihantola-Vormisto, A., Muurasniemi-Isoviita, L., Nikkari, S., Oksanen, T., Porsti, I., Salminen, E. (1990) Prevention of travellers' diarrhoea by Lactobacillus GG. Ann. Med 22, 5356.
  • [222]
    Sullivan, A., Edlund, C., Nord, C.E. (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis 1, 101114.
  • [223]
    Szajewska, H., Kotowska, M., Mrukowicz, J.Z., Armanska, M., Mikolajczyk, W. (2001) Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J. Pediatr 138, 361365.
  • [224]
    Pedone, C.A., Bernabeu, A.O., Postaire, E.R., Bouley, C.F., Reinert, P. (1999) The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int. J. Clin. Pract 53, 179184.
  • [225]
    Pedone, C.A., Arnaud, C.C., Postaire, E.R., Bouley, C.F., Reinert, P. (2000) Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int. J. Clin. Pract 54, 568571.
  • [226]
    Siitonen, S., Vapaatalo, H., Salminen, S., Gordin, A., Saxelin, M., Wikberg, R., Kirkkola, A.L. (1990) Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann. Med 22, 5759.
  • [227]
    Arvola, T., Laiho, K., Torkkeli, S., Mykkanen, H., Salminen, S., Maunula, L., Isolauri, E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 104, 1999. e64
  • [228]
    Vanderhoof, J.A., Whitney, D.B., Antonson, D.L., Hanner, T.L., Lupo, J.V., Young, R.J. (1999) Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J. Pediatr 135, 564568.
  • [229]
    Pochapin, M. (2000) The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol 95, S1113.
  • [230]
    Thomas, M.R., Litin, S.C., Osmon, D.R., Corr, A.P., Weaver, A.L., Lohse, C.M. (2001) Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin. Proc 76, 883889.
  • [231]
    Cremonini, F., Di Caro, S., Nista, E.C., Bartolozzi, F., Capelli, G., Gasbarrini, G., Gasbarrini, A. (2002) Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther 16, 14611467.
  • [232]
    Cremonini, F., Di Caro, S., Santarelli, L., Gabrielli, M., Candelli, M., Nista, E.C., Lupascu, A., Gasbarrini, G., Gasbarrini, A. (2002) Probiotics in antibiotic-associated diarrhoea. Dig. Liver Dis 34 (Suppl. 2), S78S80.
  • [233]
    Hamilton-Miller, J.M. (2003) The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents 22, 360366.
  • [234]
    Mrda, Z., Zivanovic, M., Rasic, J., Gajin, S., Somer, L., Trbojevic, S., Majoros, J., Petrovic, Z. (1998) Therapy of Helicobacter pylori infection using Lactobacillus acidophilus. Med. Pregl 51, 343345.
  • [235]
    Shimizu, T., Haruna, H., Hisada, K., Yamashiro, Y. (2002) Effects of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in children. J. Antimicrob. Chemother 50, 617618.
  • [236]
    Michetti, P., Dorta, G., Wiesel, P.H., Brassart, D., Verdu, E., Herranz, M., Felley, C., Porta, N., Rouvet, M., Blum, A.L., Corthesy-Theulaz, I. (1999) Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60, 203209.
  • [237]
    Felley, C.P., Corthesy-Theulaz, I., Rivero, J.L., Sipponen, P., Kaufmann, M., Bauerfeind, P., Wiesel, P.H., Brassart, D., Pfeifer, A., Blum, A.L., Michetti, P. (2001) Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastroenterol. Hepatol 13, 2529.
  • [238]
    Gotteland, M., Cruchet, S. (2003) Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J. Antimicrob. Chemother 51, 13171319.
  • [239]
    Cruchet, S., Obregon, M.C., Salazar, G., Diaz, E., Gotteland, M. (2003) Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 19, 716721.
  • [240]
    Sakamoto, I., Igarashi, M., Kimura, K., Takagi, A., Miwa, T., Koga, Y. (2001) Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother 47, 709710.
  • [241]
    Ushiyama, A., Tanaka, K., Aiba, Y., Shiba, T., Takagi, A., Mine, T., Koga, Y. (2003) Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. J. Gastroenterol. Hepatol 18, 986991.
  • [242]
    Cats, A., Kuipers, E.J., Bosschaert, M.A., Pot, R.G., Vandenbroucke-Grauls, C.M., Kusters, J.G. (2003) Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment. Pharmacol. Ther 17, 429435.
  • [243]
    Canducci, F., Armuzzi, A., Cremonini, F., Cammarota, G., Bartolozzi, F., Pola, P., Gasbarrini, G., Gasbarrini, A. (2000) A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment. Pharmacol. Ther 14, 16251629.
  • [244]
    Wendakoon, C.N., Thomson, A.B., Ozimek, L. (2002) Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion 65, 1620.
  • [245]
    Asahara, T., Nomoto, K., Watanuki, M., Yokokura, T. (2001) Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob. Agents Chemother 45, 17511760.
  • [246]
    Silva De Ruiz, C., Lopez De Bocanera, M.E., Nader De Macias, M.E., Pesce De Ruiz Holgado, A.A. (1996) Effect of lactobacilli and antibiotics on E. coli urinary infections in mice. Biol. Pharm. Bull 19, 8893.
  • [247]
    Barbes, C., Boris, S. (1999) Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS 13, 747751.
  • [248]
    Reid, G., Beuerman, D., Heinemann, C., Bruce, A.W. (2001) Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol 32, 3741.
  • [249]
    Gardiner, G.E., Heinemann, C., Bruce, A.W., Beuerman, D., Reid, G. (2002) Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin. Diagn. Lab. Immunol 9, 9296.
  • [250]
    Burton, J.P., Cadieux, P.A., Reid, G. (2003) Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl. Environ. Microbiol 69, 97101.
  • [251]
    Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R., Bruce, A.W. (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol 35, 131134.
  • [252]
    Eschenbach, D.A., Davick, P.R., Williams, B.L., Klebanoff, S.J., Young-Smith, K., Critchlow, C.M., Holmes, K.K. (1989) Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol 27, 251256.
  • [253]
    Klebanoff, S.J., Hillier, S.L., Eschenbach, D.A., Waltersdorph, A.M. (1991) Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J. Infect. Dis 164, 94100.
  • [254]
    Hillier, S.L., Krohn, M.A., Klebanoff, S.J., Eschenbach, D.A. (1992) The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet. Gynecol 79, 369373.
  • [255]
    Hillier, S.L., Krohn, M.A., Rabe, L.K., Klebanoff, S.J., Eschenbach, D.A. (1993) The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin. Infect. Dis 16 (Suppl. 4), S273S281.
  • [256]
    St Amant, D.C., Valentin-Bon, I.E., Jerse, A.E. (2002) Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract. Infect. Immun 70, 71697171.
  • [257]
    Aroutcheva, A., Gariti, D., Simon, M., Shott, S., Faro, J., Simoes, J.A., Gurguis, A., Faro, S. (2001) Defense factors of vaginal lactobacilli. Am. J. Obstet. Gynecol 185, 375379.
  • [258]
    Mastromarino, P., Brigidi, P., Macchia, S., Maggi, L., Pirovano, F., Trinchieri, V., Conte, U., Matteuzzi, D. (2002) Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J. Appl. Microbiol 93, 884893.
  • [259]
    Ocana, V.S., Pesce De Ruiz Holgado, A.A., Nader-Macias, M.E. (1999) Selection of vaginal H2O2-generating Lactobacillus species for probiotic use. Curr. Microbiol 38, 279284.
  • [260]
    Ocana, V.S., De Ruiz Holgado, A.A., Nader-Macias, M.E. (1999) Growth inhibition of Staphylococcus aureus by H2O2-producing Lactobacillus paracasei subsp. paracasei isolated from the human vagina. FEMS Immunol. Med. Microbiol 23, 8792.
  • [261]
    Van de Guchte, M., Ehrlich, S.D., Maguin, E. (2001) Production of growth-inhibiting factors by Lactobacillus delbrueckii. J. Appl. Microbiol 91, 147153.
  • [262]
    Vandenbergh, P.A. (1993) Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol. Rev 12, 221238.
  • [263]
    Lehto, E.M., Salminen, S.J. (1997) Inhibition of Salmonella typhimurium adhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture supernate: only a pH effect. FEMS. Immunol. Med. Microbiol 18, 125132.
  • [264]
    Apella, M.C., Gonzalez, S.N., Nader De Macias, M.E., Romero, N., Oliver, G. (1992) In vitro studies on the growth of Shigella sonnei by Lactobacillus casei and Lact. acidophilus. J. Appl. Bacteriol 73, 480483.
  • [265]
    Brashears, M.M., Reilly, S.S., Gilliland, S.E. (1998) Antagonistic action of cells of Lactobacillus lactis toward Escherichia coli 0157:H7 on refrigerated raw chicken meat. J. Food Prot 61, 166170.
  • [266]
    Ogawa, M., Shimizu, K., Nomoto, K., Tanaka, R., Hamabata, T., Yamasaki, S., Takeda, T., Takeda, Y. (2001) Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int. J. Food Microbiol 68, 135140.
  • [267]
    Strus, M., Pakosz, K., Gosciniak, H., Przondo-Mordarska, A., Rozynek, E., Pituch, H., Meisel-Mikolajczyk, F., Heczko, P.B. (2001) Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile). Med. Dosw. Mikrobiol 53, 133142.
  • [268]
    Bhatia, S.J., Kochar, N., Abraham, P., Nair, N.G., Mehta, A.P. (1989) Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J. Clin. Microbiol 27, 23282330.
  • [269]
    Midolo, P.D., Lambert, J.R., Hull, R., Luo, F., Grayson, M.L. (1995) In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol 79, 475479.
  • [270]
    Jin, L.Z., Ho, Y.W., Abdullah, N., Ali, M.A., Jalaludin, S. (1996) Antagonistic effects of intestinal Lactobacillus isolates on pathogens of chicken. Lett. Appl. Microbiol 23, 6771.
  • [271]
    Niku-Paavola, M.L., Laitila, A., Mattila-Sandholm, T., Haikara, A. (1999) New types of antimicrobial compounds produced by Lactobacillus plantarum. J. Appl. Microbiol 86, 2935.
  • [272]
    Alakomi, H.L., Skytta, E., Saarela, M., Mattila-Sandholm, T., Latva-Kala, K., Helander, I.M. (2000) Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl. Environ. Microbiol 66, 20012005.
  • [273]
    Gan, B.S., Kim, J., Reid, G., Cadieux, P., Howard, J.C. (2002) Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis 185, 13691372.
  • [274]
    Reid, G., Lam, D., Bruce, A.W., van der Mei, H.C., Busscher, H.J. (1994) Adhesion of lactobacilli to urinary catheters and diapers: effect of surface properties. J. Biomed. Mater. Res 28, 731734.
  • [275]
    Reid, G. (1995) Adhesion of urogenital organisms to polymers and prosthetic devices. Methods Enzymol 253, 514519.
  • [276]
    Velraeds, M.M., van der Mei, H.C., Reid, G., Busscher, H.J. (1996) Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl. Environ. Microbiol 62, 19581963.
  • [277]
    Shanahan, F. (1999) Intestinal lymphoepithelial communication. Adv. Exp. Med. Biol 473, 19.
  • [278]
    Delneste, Y., Donnet-Hughes, A., Schiffrin, E.J. (1998) Functional foods: mechanisms of action on immunocompetent cells. Nutr. Rev 56, S9398.
  • [279]
    Perdigon, G., Fuller, R., Raya, R. (2001) Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol 2, 2742.
  • [280]
    Gershwin, M.E., Schiffrin, E. (2002) Probiotics and immunity. Introduction. Clin. Rev. Allergy Immunol 22, 205206.
  • [281]
    Schiffrin, E.J., Blum, S. (2002) Interactions between the microbiota and the intestinal mucosa. Eur. J. Clin. Nutr 56 (Suppl. 3), S60S64.
  • [282]
    Blum, S., Schiffrin, E.J. (2003) Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria. Curr. Issues Intest. Microbiol 4, 5360.
  • [283]
    Klebanoff, S.J., Watts, D.H., Mehlin, C., Headley, C.M. (1999) Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB. J. Infect. Dis 179, 653660.
  • [284]
    Chen, T., Isomaki, P., Rimpilainen, M., Toivanen, P. (1999) Human cytokine responses induced by gram-positive cell walls of normal intestinal microbiota. Clin. Exp. Immunol 118, 261267.
  • [285]
    Miettinen, M., Vuopio-Varkila, J., Varkila, K. (1996) Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun 64, 54035405.
  • [286]
    Rangavajhyala, N., Shahani, K.M., Sridevi, G., Srikumaran, S. (1997) Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages. Nutr. Cancer 28, 130134.
  • [287]
    Matar, C., Valdez, J.C., Medina, M., Rachid, M., Perdigon, G. (2001) Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. Dairy Res 68, 601609.
  • [288]
    Leblanc, J.G., Matar, C., Valdez, J.C., Leblanc, J., Perdigon, G. (2002) Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci 85, 27332742.
  • [289]
    Morita, H., He, F., Fuse, T., Ouwehand, A.C., Hashimoto, H., Hosoda, M., Mizumachi, K., Kurisaki, J. (2002) Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci. Biotechnol. Biochem 66, 19631966.
  • [290]
    Hessle, C., Hanson, L.A., Wold, A.E. (1999) Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin. Exp. Immunol 116, 276282.
  • [291]
    Kato, I., Tanaka, K., Yokokura, T. (1999) Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. Int. J Immunopharmacol 21, 121131.
  • [292]
    Tejada-Simon, M.V., Ustunol, Z., Pestka, J.J. (1999) Ex vivo effects of lactobacilli, streptococci, and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model. J. Food Protect 62, 162169.
  • [293]
    Tejada-Simon, M.V., Pestka, J.J. (1999) Proinflammatory cytokine and nitric oxide induction in murine macrophages by cell wall and cytoplasmic extracts of lactic acid bacteria. J. Food Protect 62, 14351444.
  • [294]
    Tejada-Simon, M.V., Ustunol, Z., Pestka, J.J. (1999) Effects of lactic acid bacteria ingestion of basal cytokine mRNA and immunoglobulin levels in the mouse. J. Food Protect 62, 287291.
  • [295]
    Korhonen, R., Korpela, R., Saxelin, M., Maki, M., Kankaanranta, H., Moilanen, E. (2001) Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation 25, 223232.
  • [296]
    He, F., Morita, H., Ouwehand, A.C., Hosoda, M., Hiramatsu, M., Kurisaki, J., Isolauri, E., Benno, Y., Salminen, S. (2002) Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol. Immunol 46, 781785.
  • [297]
    Coconnier, M.H., Lievin, V., Lorrot, M., Servin, A.L. (2000) Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 Cells. Appl. Environ. Microbiol 66, 11521157.
  • [298]
    Lammers, K.M., Helwig, U., Swennen, E., Rizzello, F., Venturi, A., Caramelli, E., Kamm, M.A., Brigidi, P., Gionchetti, P., Campieri, M. (2002) Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am. J. Gastroenterol 97, 11821186.
    Direct Link:
  • [299]
    Morita, H., He, F., Fuse, T., Ouwehand, A.C., Hashimoto, H., Hosoda, M., Mizumachi, K., Kurisaki, J. (2002) Adhesion of lactic acid bacteria to Caco-2 cells and their effect on cytokine secretion. Microbiol. Immunol 46, 293297.
  • [300]
    Wallace, T.D., Bradley, S., Buckley, N.D., Green-Johnson, J.M. (2003) Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J. Food Protect 66, 466472.
  • [301]
    Mccracken, V.J., Chun, T., Baldeon, M.E., Ahrne, S., Molin, G., Mackie, R.I., Gaskins, H.R. (2002) TNF-alpha sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp. Biol. Med 227, 665670.
  • [302]
    Haller, D., Bode, C., Hammes, W.P., Pfeifer, A.M., Schiffrin, E.J., Blum, S. (2000) Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47, 7987.
  • [303]
    Borruel, N., Casellas, F., Antolin, M., Llopis, M., Carol, M., Espiin, E., Naval, J., Guarner, F., Malagelada, J.R. (2003) Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am. J. Gastroenterol 98, 865870.
    Direct Link:
  • [304]
    Christensen, H.R., Frokiaer, H., Pestka, J.J. (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol 168, 171178.
  • [305]
    Vidal, K., Donnet-Hughes, A., Granato, D. (2002) Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram- negative bacteria. Infect. Immun 70, 20572064.
  • [306]
    Haller, D., Serrant, P., Granato, D., Schiffrin, E.J., Blum, S. (2002) Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes. Clin. Diagn. Lab. Immunol 9, 649657.
  • [307]
    Ibnou-Zekri, N., Blum, S., Schiffrin, E.J., von Der Weid, T. (2003) Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect. Immun 71, 428436.
  • [308]
    Zalashko, M.V., Anisimova, H.I., Bortkevich, L.G. (1997) Antimicrobial and immunomodulatory activities of Lactobacillus acidophilus Ke-10. Prikl. Biokhim. Mikrobiol 33, 305309.
  • [309]
    Link-Amster, H., Rochat, F., Saudan, K.Y., Mignot, O., Aeschlimann, J.M. (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol 10, 5563.
  • [310]
    Schiffrin, E.J., Rochat, F., Link-Amster, H., Aeschlimann, J.M., Donnet-Hughes, A. (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci 78, 491497.
  • [311]
    Schiffrin, E.J., Brassart, D., Servin, A.L., Rochat, F., Donnet-Hughes, A. (1997) Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr 66, 515S520S.
  • [312]
    Yasui, H., Shida, K., Matsuzaki, T., Yokokura, T. (1999) Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 76, 383389.
  • [313]
    Matsuzaki, T. (1998) Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol 41, 133140.
  • [314]
    Matsuzaki, T., Chin, J. (2000) Modulating immune responses with probiotic bacteria. Immunol. Cell Biol 78, 6773.
  • [315]
    Hori, T., Kiyoshima, J., Yasui, H. (2003) Effect of an oral administration of Lactobacillus casei strain Shirota on the natural killer activity of blood mononuclear cells in aged mice. Biosci. Biotechnol. Biochem 67, 420422.
  • [316]
    Yan, F., Polk, D.B. (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem 277, 5095950965.
  • [317]
    Pena, J.A., Versalovic, J. (2003) Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell. Microbiol 5, 277285.
  • [318]
    Veckman, V., Miettinen, M., Matikainen, S., Lande, R., Giacomini, E., Coccia, E.M., Julkunen, I. (2003) Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J. Leukoc. Biol 74, 395402.
  • [319]
    Kirjavainen, P.V., Elnezami, H.S., Salminen, S.J., Ahokas, J.T., Wright, P.F. (1999) Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clin. Diagn. Lab. Immunol 6, 799802.
  • [320]
    Fang, H., Elina, T., Heikki, A., Seppo, S. (2000) Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol 29, 4752.
  • [321]
    Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M., Vesikari, T. (1995) Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13, 310312.
  • [322]
    Schultz, M., Linde, H.J., Lehn, N., Zimmermann, K., Grossmann, J., Falk, W., Scholmerich, J. (2003) Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J. Dairy Res 70, 165173.
  • [323]
    Gill, H.S., Rutherfurd, K.J., Prasad, J., Gopal, P.K. (2000) Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr 83, 167176.
  • [324]
    Kirjavainen, P.V., El-Nezami, H.S., Salminen, S.J., Ahokas, J.T., Wright, P.F. (1999) The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol. Med. Microbiol 26, 131135.
  • [325]
    Perdigon, G., Alvarez, S., Rachid, M., Aguero, G., Gobbato, N. (1995) Immune system stimulation by probiotics. J. Dairy Sci 78, 15971606.
  • [326]
    Perdigon, G., Maldonado Galdeano, C., Valdez, J.C., Medici, M. (2002) Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr 56 (Suppl. 4), S21S26.
  • [327]
    Perdigon, G., Vintini, E., Alvarez, S., Medina, M., Medici, M. (1999) Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci 82, 11081114.
  • [328]
    Sheih, Y.H., Chiang, B.L., Wang, L.H., Liao, C.K., Gill, H.S. (2001) Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr 20, 149156.
  • [329]
    Gill, H.S., Rutherfurd, K.J., Cross, M.L., Gopal, P.K. (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr 74, 833839.
  • [330]
    Gill, H.S., Cross, M.L., Rutherfurd, K.J., Gopal, P.K. (2001) Dietary probiotic supplementation to enhance cellular immunity in the elderly. Br. J. Biomed. Sci 58, 9496.
  • [331]
    Klaenhammer, T.R. (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev 12, 3985.
  • [332]
    Jack, R.W., Tagg, J.R., Ray, B. (1995) Bacteriocins of gram-positive bacteria. Microbiol. Rev 59, 171200.
  • [333]
    Mcauliffe, O., Ross, R.P., Hill, C. (2001) Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol. Rev 25, 285308.
  • [334]
    Ennahar, S., Sashihara, T., Sonomoto, K., Ishizaki, A. (2000) Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol. Rev 24, 85106.
  • [335]
    Nes, I.F., Holo, H. (2000) Class II antimicrobial peptides from lactic acid bacteria. Biopolymers 55, 5061.
  • [336]
    Sablon, E., Contreras, B., Vandamme, E. (2000) Antimicrobial peptides of lactic acid bacteria: mode of action, genetics and biosynthesis. Adv. Biochem. Eng. Biotechnol 68, 2160.
  • [337]
    Kim, T.S., Hur, J.W., Yu, M.A., Cheigh, C.I., Kim, K.N., Hwang, J.K., Pyun, Y.R. (2003) Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J. Food Protect 66, 312.
  • [338]
    Stevens, K.A., Sheldon, B.W., Klapes, N.A., Klaenhammer, T.R. (1991) Nisin treatment for inactivation of Salmonella species and other gram-negative bacteria. Appl. Environ. Microbiol 57, 36133615.
  • [339]
    Zamfir, M., Callewaert, R., Cornea, P.C., Savu, L., Vatafu, I., De Vuyst, L. (1999) Purification and characterization of a bacteriocin produced by Lactobacillus acidophilus IBB 801. J Appl Microbiol 87, 923931.
  • [340]
    Zamfir, M., Callewaert, R., Cornea, P.C., De Vuyst, L. (2000) Production kinetics of acidophilin 801, a bacteriocin produced by Lactobacillus acidophilus IBB 801. FEMS Microbiol. Lett 190, 305308.
  • [341]
    Cleveland, J., Montville, T.J., Nes, I.F., Chikindas, M.L. (2001) Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol 71, 120.
  • [342]
    Vescovo, M., Scolari, G.L., Caravaggi, L., Bottazzi, V. (1993) Antimicrobial compounds from Lactobacillus casei and Lactobacillus helveticus. New Microbiol 16, 171175.
  • [343]
    Silva, M., Jacobus, N., Deneke, C., Gorbach, S.L. (1987) Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother 31, 12311233.
  • [344]
    Mcgroarty, J.A., Reid, G. (1988) Detection of a Lactobacillus substance that inhibits Escherichia coli. Can. J. Microbiol 34, 974978.
  • [345]
    Perez, P.F., Minnaard, J., Rouvet, M., Knabenhans, C., Brassart, D., De Antoni, G.L., Schiffrin, E.J. (2001) Inhibition of Giardia intestinalis by extracellular factors from lactobacilli: an in vitro study. Appl. Environ. Microbiol 67, 50375042.
  • [346]
    Lorca, G.L., Wadstrom, T., Valdez, G.F., Ljungh, A. (2001) Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr. Microbiol 42, 3944.
  • [347]
    Lesuffleur, T., Barbat, A., Dussaulx, E., Zweibaum, A. (1990) Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50, 63346343.
  • [348]
    Van den Brink, G.R., Tytgat, K.M., van der Hulst, R.W., van der Loos, C.M., Einerhand, A.W., Buller, H.A., Dekker, J. (2000) H. pylori colocalises with MUC5AC in the human stomach. Gut 46, 601607.
  • [349]
    Mukai, T., Asasaka, T., Sato, E., Mori, K., Matsumoto, M., Ohori, H. (2002) Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol. Med. Microbiol 32, 105110.
  • [350]
    Callewaert, R., De Vuyst, L. (2000) Bacteriocin production with Lactobacillus amylovorus DCE 471 is improved and stabilized by fed-batch fermentation. Appl. Environ. Microbiol 66, 606613.
  • [351]
    Messens, W., Neysens, P., Vansieleghem, W., Vanderhoeven, J., De Vuyst, L. (2002) Modeling growth and bacteriocin production by Lactobacillus amylovorus DCE 471 in response to temperature and pH values used for sourdough fermentations. Appl. Environ. Microbiol 68, 14311435.
  • [352]
    Neysens, P., Messens, W., De Vuyst, L. (2003) Effect of sodium chloride on growth and bacteriocin production by Lactobacillus amylovorus DCE 471. Int. J. Food Microbiol 88, 2939.
  • [353]
    Leroy, F., De Vuyst, L. (1999) The presence of salt and a curing agent reduces bacteriocin production by Lactobacillus sakei CTC 494, a potential starter culture for sausage fermentation. Appl. Environ. Microbiol 65, 53505356.
  • [354]
    Leroy, F., De Vuyst, L. (2003) A combined model to predict the functionality of the bacteriocin-producing Lactobacillus sakei strain CTC 494. Appl. Environ. Microbiol 69, 10931099.
  • [355]
    Diep, D.B., Myhre, R., Johnsborg, O., Aakra, A., Nes, I.F. (2003) Inducible bacteriocin production in Lactobacillus is regulated by differential expression of the pln operons and by two antagonizing response regulators, the activity of which is enhanced upon phosphorylation. Mol. Microbiol 47, 483494.
  • [356]
    Risoen, P.A., Brurberg, M.B., Eijsink, V.G., Nes, I.F. (2000) Functional analysis of promoters involved in quorum sensing-based regulation of bacteriocin production in Lactobacillus. Mol. Microbiol 37, 619628.
  • [357]
    Risoen, P.A., Johnsborg, O., Diep, D.B., Hamoen, L., Venema, G., Nes, I.F. (2001) Regulation of bacteriocin production in Lactobacillus plantarum depends on a conserved promoter arrangement with consensus binding sequence. Mol. Genet. Genomics 265, 198206.
  • [358]
    Fasano, A. (1999) Cellular microbiology: can we learn cell physiology from microorganisms. Am. J. Physiol 276, C765776.
  • [359]
    Uzzau, S., Fasano, A. (2000) Cross-talk between enteric pathogens and the intestine. Cell. Microbiol 2, 8389.
  • [360]
    Dramsi, S., Cossart, P. (1998) Intracellular pathogens and the actin cytoskeleton. Annu. Rev. Cell Dev. Biol 14, 137166.
  • [361]
    Bernet-Camard, M.F., Coconnier, M.H., Hudault, S., Servin, A.L. (1996) Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells. Infect. Immun 64, 19181928.
  • [362]
    Peiffer, I., Servin, A.L., Bernet-Camard, M.F. (1998) Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells. Infect. Immun 66, 40364042.
  • [363]
    Peiffer, I., Guignot, J., Barbat, A., Carnoy, C., Moseley, S.L., Nowicki, B., Servin, A.L., Bernet-Camard, M.F. (2000) Structural and functionnal lesions in brush border of human polarized intestinal Caco-2/TC7 cells infected by members of the Afa/Dr diffusely adhering family of Escherichia coli. Infect. Immun 68, 59795990.
  • [364]
    Peiffer, I., Bernet-Camard, M.F., Rousset, M., Servin, A.L. (2001) Impairments in enzyme activity and biosynthesis of brush border- associated hydrolases in human intestinal Caco-2/TC7 cells infected by members of the Afa/Dr family of diffusely adhering Escherichia coli. Cell. Microbiol 3, 341357.
  • [365]
    Lievin-Le Moal, V., Amsellem, R., Servin, A.L., Coconnier, M.H. (2002) Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells. Gut 50, 803811.
  • [366]
    Michail, S., Abernathy, F. (2003) Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr 36, 385391.
  • [367]
    Czerucka, D., Rampal, P. (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4, 733739.
  • [368]
    Czerucka, D., Dahan, S., Mograbi, B., Rossi, B., Rampal, P. (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect. Immun 68, 59986004.
  • [369]
    Czerucka, D., Rampal, P. (1999) Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells. Dig. Dis. Sci 44, 23592368.
  • [370]
    Czerucka, D., Roux, I., Rampal, P. (1994) Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3,5-cyclic monophosphate induction in intestinal cells. Gastroenterology 106, 6572.
  • [371]
    Czerucka, D., Nano, J.L., Bernasconi, P., Rampal, P. (1989) Response to cholera toxin of 2 epithelial intestinal cell lines. Effect of Saccharomyces boulardii. Gastroenterol. Clin. Biol 13, 383387.
  • [372]
    Dahan, S., Dalmasso, G., Imbert, V., Peyron, J.F., Rampal, P., Czerucka, D. (2003) Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect. Immun 71, 766773.
  • [373]
    Desreumaux, P., Colombel, J.F. (2003) Intestinal flora and Crohn's disease. Ann. Pharm. Fr 61, 276281.
  • [374]
    Hata, K., Andoh, A., Sato, H., Araki, Y., Tanaka, M., Tsujikawa, T., Fujiyama, Y., Bamba, T. (2001) Sequential changes in luminal microflora and mucosal cytokine expression during developing of colitis in HLA-B27/beta2-microglobulin transgenic rats. Scand. J. Gastroenterol 36, 11851192.
  • [375]
    Bulois, P., Desreumaux, P., Neut, C., Darfeuille-Michaud, A., Cortot, A., Colombel, J.F. (1999) Infectious agents and Crohn's disease. Clin. Microbiol. Infect 5, 601604.
  • [376]
    Langman, M.J., Allan, R.N. (1999) Escherichia coli for ulcerative colitis. Lancet 354, 20002001.
  • [377]
    Shen, W., Steinruck, H., Ljungh, A. (1995) Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases. Gut 36, 401406.
  • [378]
    Tiveljung, A., Soderholm, J.D., Olaison, G., Jonasson, J., Monstein, H.J. (1999) Presence of eubacteria in biopsies from Crohn's disease inflammatory lesions as determined by 16S rRNA gene-based PCR. J. Med. Microbiol 48, 263268.
  • [379]
    Schultsz, C., Moussa, M., Van Ketel, R., Tytgat, G.N., Dankert, J. (1997) Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J. Clin. Pathol 50, 573579.
  • [380]
    Boudeau, J., Glasser, A.L., Masseret, E., Joly, B., Darfeuille-Michaud, A. (1999) Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun 67, 44994509.
  • [381]
    Boudeau, J., Barnich, N., Darfeuille-Michaud, A. (2001) Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol. Microbiol 39, 12721284.
  • [382]
    Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., Gambiez, L., Joly, B., Cortot, A., Colombel, J.F. (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115, 14051413.
  • [383]
    Hartley, M.G., Hudson, M.J., Swarbrick, E.T., Gent, A.E., Hellier, M.D., Grace, R.H. (1993) Adhesive and hydrophobic properties of Escherichia coli from the rectal mucosa of patients with ulcerative colitis. Gut 34, 6367.
  • [384]
    Masseret, E., Boudeau, J., Colombel, J.F., Neut, C., Desreumaux, P., Joly, B., Cortot, A., Darfeuille-Michaud, A. (2001) Genetically related Escherichia coli strains associated with Crohn's disease. Gut 48, 320325.
  • [385]
    Seksik, P., Rigottier-Gois, L., Gramet, G., Sutren, M., Pochart, P., Marteau, P., Jian, R., Dore, J. (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237242.
  • [386]
    Betis, F., Brest, P., Hofman, V., Guignot, J., Bernet-Camard, M.F., Rossi, B., Servin, A., Hofman, P. (2003) The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells. Infect. Immun 71, 10681074.
  • [387]
    Tieng, V., le Bouguenec, C., Du Merle, L., Bertheau, P., Desreumaux, P., Janin, A., Charron, D., Toubert, A. (2002) Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl. Acad. Sci. USA 99, 29772982.
  • [388]
    Andoh, A., Fujiyama, Y., Sumiyoshi, K., Sakumoto, H., Bamba, T. (1996) Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology 111, 911918.
  • [389]
    Andoh, A., Fujiyama, Y., Sumiyoshi, K., Sakumoto, H., Okabe, H., Bamba, T. (1997) Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells. Immunology 90, 358363.
  • [390]
    Berstad, A.E., Brandtzaeg, P. (1998) Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut 42, 522529.
  • [391]
    Bjorge, L., Jensen, T.S., Matre, R. (1996) Characterisation of the complement-regulatory proteins decay- accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line. Cancer Immunol. Immunother 42, 185192.
  • [392]
    Uesu, T., Mizuno, M., Inoue, H., Tomoda, J., Tsuji, T. (1995) Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis. Lab. Invest 72, 587591.
  • [393]
    Schmitt, C.A., Schwaeble, W., Wittig, B.M., Meyer Zum Buschenfelde, K.H., Dippold, W.G. (1999) Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours. Eur. J. Cancer 35, 117124.
  • [394]
    Nasu, J., Mizuno, M., Uesu, T., Takeuchi, K., Inaba, T., Ohya, S., Kawada, M., Shimo, K., Okada, H., Fujita, T., Tsuji, T. (1998) Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells. Clin. Exp. Immunol 113, 379385.
  • [395]
    Gionchetti, P., Amadini, C., Rizzello, F., Venturi, A., Campieri, M. (2002) Review article: treatment of mild to moderate ulcerative colitis and pouchitis. Aliment. Pharmacol. Ther 16 (Suppl. 4), 1319.
  • [396]
    Shanahan, F. (2000) Probiotics and inflammatory bowel disease: is there a scientific rationale. Inflamm. Bowel Dis 6, 107115.
  • [397]
    Shanahan, F. Probiotics in inflamatory bowel disease. Gut. 48, 2001. 609
  • [398]
    Shanahan, F. (2002) Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br. J. Nutr 88 (Suppl. 1), S5S9.
  • [399]
    Shanahan, F. (2002) Crohn's disease. Lancet 359, 6269.
  • [400]
    Shanahan, F. Probiotics: a perspective on problems and pitfalls. Scand. J. Gastroenterol. Suppl. 2003. 34–36
  • [401]
    Tamboli, C.P., Caucheteux, C., Cortot, A., Colombel, J.F., Desreumaux, P. (2003) Probiotics in inflammatory bowel disease: a critical review. Best Pract. Res. Clin. Gastroenterol 17, 805820.
  • [402]
    Madsen, K.L., Doyle, J.S., Jewell, L.D., Tavernini, M.M., Fedorak, R.N. (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 11071114.
  • [403]
    Schultz, M., Veltkamp, C., Dieleman, L.A., Grenther, W.B., Wyrick, P.B., Tonkonogy, S.L., Sartor, R.B. (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis 8, 7180.
  • [404]
    Mccarthy, J., O'mahony, L., O'callaghan, L., Sheil, B., Vaughan, E.E., Fitzsimons, N., Fitzgibbon, J., O'sullivan, G.C., Kiely, B., Collins, J.K., Shanahan, F. (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin10 knockout mice and mechanistic link with cytokine balance. Gut 52, 975980.
  • [405]
    O'mahony, L., Feeney, M., O'halloran, S., Murphy, L., Kiely, B., Fitzgibbon, J., Lee, G., O'sullivan, G., Shanahan, F., Collins, J.K. (2001) Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment. Pharmacol. Ther 15, 12191225.
  • [406]
    Madsen, K., Cornish, A., Soper, P., Mckaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., De Simone, C. (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580591.
  • [407]
    Dianda, L., Hanby, A.M., Wright, N.A., Sebesteny, A., Hayday, A.C., Owen, M.J. (1997) T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol 150, 9197.
  • [408]
    Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P.A., Moser, A.B., Desimone, C., Song, X.Y., Diehl, A.M. (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37, 343350.
  • [409]
    Pavan, S., Desreumaux, P., Mercenier, A. (2003) Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clin. Diagn. Lab. Immunol 10, 696701.
  • [410]
    Shibolet, O., Karmeli, F., Eliakim, R., Swennen, E., Brigidi, P., Gionchetti, P., Campieri, M., Morgenstern, S., Rachmilewitz, D. (2002) Variable response to probiotics in two models of experimental colitis in rats. Inflamm. Bowel Dis 8, 399406.
  • [411]
    Dieleman, L.A., Goerres, M.S., Arends, A., Sprengers, D., Torrice, C., Hoentjen, F., Grenther, W.B., Sartor, R.B. (2003) Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52, 370376.
  • [412]
    Floch, M.H. (2003) Probiotics, irritable bowel syndrome, and inflammatory bowel disease. Curr. Treat. Options Gastroenterol 6, 283288.
  • [413]
    Bianchi-Salvadori, B., Vesely, R., Ferrari, A., Canzi, E., Casiraghi, C., Brighenti, F. (2001) Behaviour of the pharmaceutical probiotic preparation VSL#3 in human ileostomy effluent containing its own natural elements. New Microbiol 24, 2333.
  • [414]
    Brigidi, P., Swennen, E., Vitali, B., Rossi, M., Matteuzzi, D. (2003) PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. Int. J. Food Microbiol 81, 203209.
  • [415]
    Venturi, A., Gionchetti, P., Rizzello, F., Johansson, R., Zucconi, E., Brigidi, P., Matteuzzi, D., Campieri, M. (1999) Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther 13, 11031108.
  • [416]
    Kim, H.J., Camilleri, M., Mckinzie, S., Lempke, M.B., Burton, D.D., Thomforde, G.M., Zinsmeister, A.R. (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther 17, 895904.
  • [417]
    Malin, M., Suomalainen, H., Saxelin, M., Isolauri, E. (1996) Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann. Nutr. Metab 40, 137145.
  • [418]
    Guandalini, S. (2002) Use of Lactobacillus-GG in paediatric Crohn's disease. Dig. Liver Dis 34 (Suppl. 2), S63S65.
  • [419]
    Prantera, C., Scribano, M.L. (2002) Probiotics and Crohn's disease. Dig. Liver Dis 34 (Suppl. 2), S6667.
  • [420]
    Halpern, G.M., Prindiville, T., Blankenburg, M., Hsia, T., Gershwin, M.E. (1996) Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am. J. Gastroenterol 91, 15791585.
  • [421]
    Bulois, P., Tremaine, W.J., Maunoury, V., Gambiez, L., Hafraoui, S., Leteurtre, L., Cortot, A., Sandborn, W.J., Colombel, J.F., Desreumaux, P. (2000) Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm. Bowel Dis 6, 157164.
  • [422]
    Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., Campieri, M. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 305309.
  • [423]
    Sandborn, W.J., Mcleod, R., Jewell, D.P. (1999) Medical therapy for induction and maintenance of remission in pouchitis: a systematic review. Inflamm. Bowel Dis 5, 3339.
  • [424]
    Sandborn, W., Mcleod, R., Jewell, D. Pharmacotherapy for inducing and maintaining remission in pouchitis. Cochrane Database Syst. Rev. CD001176. 2000
  • [425]
    Kuisma, J., Mentula, S., Jarvinen, H., Kahri, A., Saxelin, M., Farkkila, M. (2003) Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment. Pharmacol. Ther 17, 509515.
  • [426]
    Hancock, R.E., Patrzykat, A. (2002) Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord 2, 7983.
  • [427]
    Koczulla, A.R., Bals, R. (2003) Antimicrobial peptides: current status and therapeutic potential. Drugs 63, 389406.
  • [428]
    Sitaram, N., Nagaraj, R. (2002) The therapeutic potential of host-defense antimicrobial peptides. Curr. Drug Targets 3, 259267.
  • [429]
    Van 'T Hof, W., Veerman, E.C., Helmerhorst, E.J., Amerongen, A.V. (2001) Antimicrobial peptides: properties and applicability. Biol. Chem 382, 597619.
  • [430]
    Zasloff, M. (2002) Antimicrobial peptides in health and disease. N. Engl. J. Med 347, 11991200.
  • [431]
    Huang, H.W. (1999) Peptide–lipid interactions and mechanisms of antimicrobial peptides. Novart. Found. Symp 225, 188200.
  • [432]
    Shai, Y. (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66, 236248.
  • [433]
    Helander, I.M., Mattila-Sandholm, T. (2000) Permeability barrier of the gram-negative bacterial outer membrane with special reference to nisin. Int. J. Food Microbiol 60, 153161.
  • [434]
    Moll, G.N., Konings, W.N., Driessen, A.J. (1999) Bacteriocins: mechanism of membrane insertion and pore formation. Antonie Van Leeuwenhoek 76, 185198.
  • [435]
    Chauviere, G., Coconnier, M.H., Kerneis, S., Darfeuille-Michaud, A., Joly, B., Servin, A.L. (1992) Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus. FEMS Microbiol. Lett 70, 213217.
  • [436]
    Shu, Q., Gill, H.S. (2002) Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol 34, 5964.
  • [437]
    Nagao, F., Nakayama, M., Muto, T., Okumura, K. (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci. Biotechnol. Biochem 64, 27062708.